Biogen Inc (BIIB)
146.47
-0.92
(-0.62%)
USD |
NASDAQ |
Dec 20, 16:00
147.55
+1.08
(+0.74%)
After-Hours: 20:00
Biogen Free Cash Flow: 1.768B for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly and Co | -2.275B |
| Pfizer Inc | 8.227B |
| Regeneron Pharmaceuticals Inc | 3.319B |
| Sage Therapeutics Inc | -320.15M |
| Moderna Inc | -3.956B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 935.60M |
| Cash from Investing (Quarterly) | -1.181B |
| Cash from Financing (Quarterly) | -6.60M |
| Free Cash Flow Per Share (Quarterly) | 5.514 |
| Free Cash Flow to Equity (Quarterly) | 803.70M |
| Free Cash Flow to Firm (Quarterly) | 847.12M |
| Free Cash Flow Yield | 8.27% |